Sen. Bill Cassidy (R-LA) stated on Sunday that Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has overseen a "series of failures" during his tenure. Speaking on "Face the Nation," Cassidy argued that the president should choose someone else to ensure accountability for rising health care costs and the United States losing its measles elimination status.
The disagreement marks a shift for Cassidy, a medical doctor who supported Kennedy’s confirmation last year after receiving what he described as "serious commitments" from the administration. Cassidy, who is set to leave the Senate early next year following a lost reelection bid, said the promised "collaborative working relationship" with the HHS Secretary has not appeared to pan out.
The exchange follows a Nov. 9 statement from Kennedy, who suggested that Senate Republicans had hindered his "Make America Healthy Again" (MAHA) agenda. Kennedy stated that because Republicans are set to lose their Senate majority in the new year, the chamber would no longer have "leverage" over his actions. Cassidy dismissed these comments as an attempt to "provide cover" for a lack of progress on a promised crackdown on ultra-processed foods.
The scale of the impact is defined by the loss of the U.S. measles elimination status, a formal designation indicating that a disease is no longer constantly present in a country. While specific national death tolls were not reported, Cassidy cited the occurrence of infant deaths and risks to pregnant women and immunocompromised individuals. Within the healthcare market, Cassidy pointed to "higher health care costs" as a failure, though the exact dollar increase per household was not reported.
The knock-on effects include a potential impact on the legacy of the president, whom Cassidy urged to seek a leadership change at HHS. While some Democrats have discussed the possibility of impeachment, Cassidy stated that they would have to decide what to do on that, noting the process can be applied broadly. What happens next depends on the HELP committee, which is scheduled to vote on Heidi Overton’s nomination for Food and Drug Administration (FDA) commissioner this week. Cassidy stated he remains undecided on whether her nomination has enough support to advance.